After losing the drug pricing fight on Capitol Hill, PhRMA, the lobbying arm of the big drug companies, is taking its battle to the courts.
The pharmaceutical industry’s biggest lobbying group filed a lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for specific medicines.
PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.
Meanwhile, the Biden Administration is moving ahead with implementing the law allowing Medicare to negotiate lower prices with drug manufacturers, despite the multiple industry lawsuits.
